Pharmaceutical companies and in particular small to medium sized ones, are in a perpetual battle to increase efficiency and reduce costs while staying GMP compliant. The always moving landscape of regulatory compliance puts significant demands on the sometimes-limited resources available to these companies. This can result in the prioritisation of activities of seemingly more importance which will inevitably, despite best efforts, lead to the neglect of others.